Diagnostics
WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board
Published in Hospital Law Weekly, November 19th, 2009
WaferGen Biosystems, Inc. (BULLETIN BOARD: WGBS) , a leading developer of state-of-the-art genetic analysis systems, announced that Christopher Sears, Ph.D. has joined the company's Scientific Advisory Board. His career has been focused on designing and commercializing novel molecular diagnostics for cancer detection and other applications, and on the development of computational biology systems for several biotechnology companies and academic institutions.
"We are very pleased to welcome Dr. Sears and I am confident that his previous successes developing diagnostic products coupled with his unique background designing critical software systems, will be highly valuable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2009-11-19)
More Articles from Hospital Law Weekly
- AGA Medical Holdings, Inc.
AGA Medical Wins Injunction Against Occlutech's Figulla Flex - Autism Consortium
Autism Consortium symposium draws record number of researchers, advocates, parents for autism update - Cancer
Whistleblower Retaliation Lawsuit Filed Against Carle Cancer Doctors and Executives in Connection with Violations of the Federal Safety Laws Protecting Patients in Experimental Clinical Cancer Trials - Commonwealth Fund
International survey of physicians in 11 countries reveals US lagging in access, quality, HIT use - Infarction
Findings from University of California provide new insights into infarction - Life Sciences
Frequency of Hospital Professional Liability Claims Increasing After Years of Declines, Says Aon and ASHRM Study Medical malpractice claims on the rise for 2010 - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
